Artificial intelligence-enabled analysis of handheld single-lead electrocardiograms to predict incident atrial fibrillation: an analysis of the VITAL-AF randomized trial
Shaan Khurshid(Massachusetts General Hospital), Patrick T. Ellinor(Broad Institute), Daniel E. Singer(Massachusetts General Hospital), Shinwan Kany(Broad Institute), Leila H. Borowsky(Massachusetts General Hospital), Jeffrey M. Ashburner(Harvard University), Jennifer E. Ho(Massachusetts General Hospital), Thomas Sommers(Hadassah Medical Center), Sam Friedman(Tektronix (United States)), Steven J. Atlas(Massachusetts General Hospital), Mahnaz Maddah(Broad Institute), David D. McManus(University of Massachusetts Chan Medical School), Steven A. Lubitz(Broad Institute), Mostafa A. Al‐Alusi(Massachusetts General Hospital), Christopher D. Anderson(St Vincent's Hospital)
Cited by 5
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Prevalence of Diagnosed Atrial Fibrillation in Adults
|JAMA|2001|6.2k
Cytokines in Inflammatory Disease
|International Journal of Molecular Sciences|2019|1.9k